Schedule 13G ownership disclosure

XILIO THERAPEUTICS INC

Security class unavailable · CUSIP: 98422T100

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
9.9660%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000315066-21-001814
Form type
SC 13G
Filer
FMR LLC
CIK
CIK 315066
Filed
Nov 04, 2021
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub